The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Sterility Testing-Global Market Insights and Sales Trends 2025
Synopsis
Sterility testing is an important part of GMP microbiology, and is used to ensure that pharmaceutical and biopharmaceutical therapeutics are sterile and safe for human use.
The global Pharmaceutical Sterility Testing market size is expected to reach US$ 1351.7 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Sterility Testing in various end use industries. The expanding demands from the Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies and Others, are propelling Pharmaceutical Sterility Testing market. Sterility Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioburden Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Sterility Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Sterility Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Sterility Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Sterility Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Sterility Testing covered in this report include SGS SA, Toxikon, Inc., Pace Analytical Services, LLC, Boston Analytical, Charles River Laboratories International, Inc. and Nelson Laboratories., etc.
The global Pharmaceutical Sterility Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SGS SA
Toxikon, Inc.
Pace Analytical Services, LLC
Boston Analytical
Charles River Laboratories International, Inc.
Nelson Laboratories.
Global Pharmaceutical Sterility Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Sterility Testing market, Segment by Type:
Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing
Global Pharmaceutical Sterility Testing market, by Application
Compounding Pharmacies
Medical Devices Companies
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Sterility Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Sterility testing is an important part of GMP microbiology, and is used to ensure that pharmaceutical and biopharmaceutical therapeutics are sterile and safe for human use.
The global Pharmaceutical Sterility Testing market size is expected to reach US$ 1351.7 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Sterility Testing in various end use industries. The expanding demands from the Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies and Others, are propelling Pharmaceutical Sterility Testing market. Sterility Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioburden Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Sterility Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Sterility Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Sterility Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Sterility Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Sterility Testing covered in this report include SGS SA, Toxikon, Inc., Pace Analytical Services, LLC, Boston Analytical, Charles River Laboratories International, Inc. and Nelson Laboratories., etc.
The global Pharmaceutical Sterility Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SGS SA
Toxikon, Inc.
Pace Analytical Services, LLC
Boston Analytical
Charles River Laboratories International, Inc.
Nelson Laboratories.
Global Pharmaceutical Sterility Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Sterility Testing market, Segment by Type:
Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing
Global Pharmaceutical Sterility Testing market, by Application
Compounding Pharmacies
Medical Devices Companies
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Sterility Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Sterility Testing
1.1 Pharmaceutical Sterility Testing Market Overview
1.1.1 Pharmaceutical Sterility Testing Product Scope
1.1.2 Pharmaceutical Sterility Testing Market Status and Outlook
1.2 Global Pharmaceutical Sterility Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Sterility Testing Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Sterility Testing Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Sterility Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Sterility Testing Market Size (2018-2029)
1.6.1 North America Pharmaceutical Sterility Testing Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Sterility Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Sterility Testing Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Sterility Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Sterility Testing Market Size (2018-2029)
2 Pharmaceutical Sterility Testing Market by Type
2.1 Introduction
2.1.1 Sterility Testing
2.1.2 Bioburden Testing
2.1.3 Bacterial Endotoxin Testing
2.2 Global Pharmaceutical Sterility Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Sterility Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Sterility Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Sterility Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Sterility Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Sterility Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Sterility Testing Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Sterility Testing Market Overview by Application
3.1 Introduction
3.1.1 Compounding Pharmacies
3.1.2 Medical Devices Companies
3.1.3 Pharmaceutical Companies
3.1.4 Others
3.2 Global Pharmaceutical Sterility Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Sterility Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Sterility Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Sterility Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Sterility Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Sterility Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Sterility Testing Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Sterility Testing Competition Analysis by Players
4.1 Global Pharmaceutical Sterility Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Sterility Testing as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Sterility Testing Market
4.4 Global Top Players Pharmaceutical Sterility Testing Headquarters and Area Served
4.5 Key Players Pharmaceutical Sterility Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Sterility Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 SGS SA
5.1.1 SGS SA Profile
5.1.2 SGS SA Main Business
5.1.3 SGS SA Pharmaceutical Sterility Testing Products, Services and Solutions
5.1.4 SGS SA Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.1.5 SGS SA Recent Developments
5.2 Toxikon, Inc.
5.2.1 Toxikon, Inc. Profile
5.2.2 Toxikon, Inc. Main Business
5.2.3 Toxikon, Inc. Pharmaceutical Sterility Testing Products, Services and Solutions
5.2.4 Toxikon, Inc. Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Toxikon, Inc. Recent Developments
5.3 Pace Analytical Services, LLC
5.3.1 Pace Analytical Services, LLC Profile
5.3.2 Pace Analytical Services, LLC Main Business
5.3.3 Pace Analytical Services, LLC Pharmaceutical Sterility Testing Products, Services and Solutions
5.3.4 Pace Analytical Services, LLC Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Boston Analytical Recent Developments
5.4 Boston Analytical
5.4.1 Boston Analytical Profile
5.4.2 Boston Analytical Main Business
5.4.3 Boston Analytical Pharmaceutical Sterility Testing Products, Services and Solutions
5.4.4 Boston Analytical Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Boston Analytical Recent Developments
5.5 Charles River Laboratories International, Inc.
5.5.1 Charles River Laboratories International, Inc. Profile
5.5.2 Charles River Laboratories International, Inc. Main Business
5.5.3 Charles River Laboratories International, Inc. Pharmaceutical Sterility Testing Products, Services and Solutions
5.5.4 Charles River Laboratories International, Inc. Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Charles River Laboratories International, Inc. Recent Developments
5.6 Nelson Laboratories.
5.6.1 Nelson Laboratories. Profile
5.6.2 Nelson Laboratories. Main Business
5.6.3 Nelson Laboratories. Pharmaceutical Sterility Testing Products, Services and Solutions
5.6.4 Nelson Laboratories. Pharmaceutical Sterility Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Nelson Laboratories. Recent Developments
6 North America
6.1 North America Pharmaceutical Sterility Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Sterility Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Sterility Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Sterility Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Sterility Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Sterility Testing Market Dynamics
11.1 Pharmaceutical Sterility Testing Industry Trends
11.2 Pharmaceutical Sterility Testing Market Drivers
11.3 Pharmaceutical Sterility Testing Market Challenges
11.4 Pharmaceutical Sterility Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
